#	Searches
1	exp breast cancer/
2	exp triple negative breast cancer/
3	Triple Negative Breast cancer$.tw.
4	Triple Negative Breast neoplasm$.tw.
5	Triple Negative Breast carcinoma$.tw.
6	Triple Negative Breast tumo?r$.tw.
7	or/1‐6
8	(local$ adj6 advance$ adj6 (breast adj6 (neoplasm$ or cancer$ or carcinoma$ or tumo?r$))).ti.
9	(metasta$ adj6 (breast adj6 (neoplasm$ or cancer$ or carcinoma$ or tumo?r$))).ti.
10	or/8‐9
11	7 not 10
12	exp cisplatin/
13	exp cisplatin derivative/
14	exp carboplatin/
15	exp platinum complex/
16	exp platinum/
17	exp platinum derivative/
18	exp platinum 1,2 diaminocyclohexane bisneodecanoate/
19	exp lobaplatin/
20	exp nedaplatin/
21	exp eptaplatin/
22	exp oxaliplatin/
23	exp miboplatin/
24	exp sebriplatin/
25	(cisplatinum or cisplat* or cisplatin).tw.
26	(carboplatinum or carboplat* or carboplatin).tw.
27	(platinum or platin*).tw.
28	platinum compound*.tw.
29	(platinum‐containing regime* or platinum containing regime*).tw.
30	(platinum‐based agent* or platinum based agent*).tw.
31	(Platinol or Platinol‐ AQ or CDDP or CACP or platidiam or platinum diamminodichloride or cis‐diamminedichloroplatinum or cis‐dichlorodiammineplatinum or biocisplatinum or dichlorodiammineplatinum or nsc‐119875 or nsc 119875 or cis‐platinum or Abiplatin or AI3‐62048 or AI3 62048 or Briplatin or CCRIS 221 or Cismaplat or Cisplatine or Cisplatyl or Neoplatin).tw.
32	(carboplatine or CCRIS 3404 or EINECS 255‐446‐0 or "EINECS 255 446 0" or HSDB 6957 or cbdca or jm‐8 or jm8 or nsc‐241240 or nsc 241240 or paraplatin or Paraplatin‐ AQ or NSC 201345 or NSC‐201345 or cis‐diammine cyclobutanedicarboxylato platinum).tw.
33	(lobaplatin or lobaplatinum or lobaplat* or D‐19466 or D 19466).tw.
34	(Nedaplatin or Aqupla or CCRIS 4088 or NSC 375101D or NSC‐375101D or cis‐Diammine glycolato platinum).tw.
35	(Heptaplatin or Eptaplatin or NSC D644591 or NSC‐D644591).tw.
36	(Oxaliplatin or oxalapatin or 1‐OHP pr CCRIS 9143 or Dacplat or Eloxatin or Elplat or JM‐83 or JM83 or l‐OHP or Lipoxal or NSC 266046 or NSC‐266046 or Oxalatoplatin or Oxalatoplatinum or Oxaliplatin or Oxaliplatino or Oxaliplatinum or Oxalitin or Oxaloplatine or Oxaloplatino or RP‐54780 or RP54780 or SR‐96669 or SR 96669).tw.
37	(miboplatin or CCRIS 5235 or DWA 2114R).tw.
38	(sebriplatin or NK 121).tw.
39	or/12‐38
40	Randomized controlled trial/
41	Controlled clinical study/
42	Random$.ti,ab.
43	randomization/
44	intermethod comparison/
45	placebo.ti,ab.
46	(compare or compared or comparison).ti.
47	(open adj label).ti,ab.
48	((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
49	double blind procedure/
50	parallel group$1.ti,ab.
51	(crossover or cross over).ti,ab.
52	((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab.
53	(assigned or allocated).ti,ab.
54	(controlled adj7 (study or design or trial)).ti,ab.
55	(volunteer or volunteers).ti,ab.
56	trial.ti.
57	or/40‐56
58	11 and 39 and 57
59	remove duplicates from 58
60	limit 59 to (human and (conference abstracts or embase))